Standard BioTools Inc. (NASDAQ: LAB)
$2.29
+0.1800 ( +8.53% ) 3.9M
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Market Data
Open
$2.29
Previous close
$2.11
Volume
3.9M
Market cap
$848.27M
Day range
$2.07 - $2.29
52 week range
$1.57 - $3.16
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Jan 09, 2024 |
8-k | 8K-related | 42 | Jan 08, 2024 |
8-k | 8K-related | 16 | Jan 05, 2024 |
8-k | 8K-related | 13 | Dec 29, 2023 |
8-k | 8K-related | 13 | Dec 26, 2023 |
8-k | 8K-related | 44 | Dec 19, 2023 |
8-k | 8K-related | 13 | Dec 04, 2023 |
8-k | 8K-related | 36 | Nov 29, 2023 |
8-k | 8K-related | 12 | Nov 21, 2023 |
10-q | Quarterly Reports | 87 | Nov 07, 2023 |